You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
| Title |
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
|
|---|---|
| Published in |
Frontiers in oncology, February 2021
|
| DOI | 10.3389/fonc.2021.650623 |
| Pubmed ID | |
| Authors |
Federico La Manna, Marta De Menna, Nikhil Patel, Sofia Karkampouna, Maria Rosaria De Filippo, Irena Klima, Peter Kloen, Lijkele Beimers, George N. Thalmann, Rob C. M. Pelger, Estela Jacinto, Marianna Kruithof-de Julio |
| Abstract |
[This corrects the article .]. |